Company Filing History:
10 out of 2,198 
1 out of 356 
Years Active: 1997-2011
Title: Lynette Jane McMillan: Innovator in IL-5 Mediated Disorders
Introduction
Lynette Jane McMillan is a prominent inventor based in Ardmore, PA (US). She has made significant contributions to the field of biotechnology, particularly in the treatment of IL-5 mediated disorders. With a total of 7 patents to her name, her work has had a substantial impact on medical research and therapeutic development.
Latest Patents
Among her latest patents are innovative recombinant IL-5 antagonists that are useful in the treatment of IL-5 mediated disorders. These include chimeric, humanized, and other IL-5 monoclonal antibodies derived from high-affinity neutralizing monoclonal antibodies. Additionally, her patents encompass pharmaceutical compositions containing these antibodies, as well as methods of treatment and diagnostics.
Career Highlights
Lynette has had a distinguished career, working with notable companies such as SmithKline Beecham Corporation and GlaxoSmithKline LLC. Her expertise in biotechnology and pharmaceuticals has allowed her to contribute to groundbreaking research and development in her field.
Collaborations
Throughout her career, Lynette has collaborated with esteemed colleagues, including Robert S. Ames and Edward Robert Appelbaum. These partnerships have further enhanced her research and innovation efforts.
Conclusion
Lynette Jane McMillan's contributions to the field of IL-5 mediated disorders exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a leading inventor in biotechnology.